SG11201408323RA - Prophylactic and/or therapeutic agent for mild cognitive impairment - Google Patents
Prophylactic and/or therapeutic agent for mild cognitive impairmentInfo
- Publication number
- SG11201408323RA SG11201408323RA SG11201408323RA SG11201408323RA SG11201408323RA SG 11201408323R A SG11201408323R A SG 11201408323RA SG 11201408323R A SG11201408323R A SG 11201408323RA SG 11201408323R A SG11201408323R A SG 11201408323RA SG 11201408323R A SG11201408323R A SG 11201408323RA
- Authority
- SG
- Singapore
- Prior art keywords
- prophylactic
- therapeutic drug
- cognitive impairment
- mild cognitive
- oral administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012135906 | 2012-06-15 | ||
| JP2012223580 | 2012-10-05 | ||
| PCT/JP2013/003740 WO2013187075A1 (fr) | 2012-06-15 | 2013-06-14 | Agent prophylactique et/ou thérapeutique pour un trouble cognitif léger |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201408323RA true SG11201408323RA (en) | 2015-01-29 |
Family
ID=49757918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201408323RA SG11201408323RA (en) | 2012-06-15 | 2013-06-14 | Prophylactic and/or therapeutic agent for mild cognitive impairment |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20150152084A1 (fr) |
| EP (1) | EP2862572B1 (fr) |
| JP (2) | JP5715303B2 (fr) |
| KR (1) | KR20150027800A (fr) |
| CN (1) | CN104519884A (fr) |
| AU (1) | AU2013275628A1 (fr) |
| BR (1) | BR112014031154A2 (fr) |
| CA (1) | CA2876371A1 (fr) |
| IL (1) | IL236226A0 (fr) |
| MX (1) | MX2014015310A (fr) |
| RU (1) | RU2015101100A (fr) |
| SG (1) | SG11201408323RA (fr) |
| WO (1) | WO2013187075A1 (fr) |
| ZA (1) | ZA201409134B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2876371A1 (fr) * | 2012-06-15 | 2013-12-19 | Foundation For Biomedical Research And Innovation | Agent prophylactique et/ou therapeutique pour un trouble cognitif leger |
| MX2018007791A (es) * | 2015-12-25 | 2018-11-09 | Otsuka Pharma Co Ltd | Farmaco que comprende aripiprazol y cilostazol. |
| CN109310688B (zh) | 2016-05-19 | 2023-09-01 | 国立研究开发法人国立循环器病研究中心 | 用于预防和/或治疗痴呆症的药物 |
| JP6501425B2 (ja) * | 2017-05-31 | 2019-04-17 | 学校法人藤田学園 | Ａβ除去システム |
| WO2021230131A1 (fr) * | 2020-05-11 | 2021-11-18 | 株式会社島津製作所 | Agent thérapeutique pour déficience cognitive légère |
| WO2022270663A1 (fr) * | 2021-06-23 | 2022-12-29 | 동아에스티 주식회사 | Composition pharmaceutique comprenant du donépézil, du cilostazol et de l'aripiprazole pour la prévention, le soulagement ou le traitement de la démence, de la déficience cognitive ou de la dépression vasculaire |
| WO2024054201A1 (fr) * | 2022-09-06 | 2024-03-14 | The Johns Hopkins University | Plate-forme optogénique de criblagae de composés fondée sur le système d'aggregation des alpha-synucléines dans les neurones pd-hipsc-mda |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080113025A1 (en) | 1998-11-02 | 2008-05-15 | Elan Pharma International Limited | Compositions comprising nanoparticulate naproxen and controlled release hydrocodone |
| US20080102121A1 (en) | 1998-11-02 | 2008-05-01 | Elan Pharma International Limited | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
| CA2348871C (fr) | 1998-11-02 | 2009-04-14 | John G. Devane | Composition a liberation modifiee multiparticulaire |
| US20090297602A1 (en) | 1998-11-02 | 2009-12-03 | Devane John G | Modified Release Loxoprofen Compositions |
| US20080118556A1 (en) | 1998-11-02 | 2008-05-22 | Elan Corporation, Plc | Modified Release of Compositions Containing a Combination of Carbidopa, Levodopa and Entacapone |
| US20070122481A1 (en) | 1998-11-02 | 2007-05-31 | Elan Corporation Plc | Modified Release Compositions Comprising a Fluorocytidine Derivative for the Treatment of Cancer |
| US20070160675A1 (en) | 1998-11-02 | 2007-07-12 | Elan Corporation, Plc | Nanoparticulate and controlled release compositions comprising a cephalosporin |
| US20090149479A1 (en) | 1998-11-02 | 2009-06-11 | Elan Pharma International Limited | Dosing regimen |
| US20060240105A1 (en) | 1998-11-02 | 2006-10-26 | Elan Corporation, Plc | Multiparticulate modified release composition |
| US20100247636A1 (en) | 1998-11-02 | 2010-09-30 | Elan Corporation, Plc | Nanoparticulate and controlled release compositions comprising nilvadipine |
| US20090297597A1 (en) | 1998-11-02 | 2009-12-03 | Gary Liversidge | Modified Release Ticlopidine Compositions |
| TWI323660B (en) * | 2003-02-25 | 2010-04-21 | Otsuka Pharma Co Ltd | Pten inhibitor or maxi-k channels opener |
| US20110064803A1 (en) | 2005-05-10 | 2011-03-17 | Elan Pharma International Limited. | Nanoparticulate and controlled release compositions comprising vitamin k2 |
| US20090297596A1 (en) | 2005-05-23 | 2009-12-03 | Elan Pharma International Limited | Nanoparticulate and Controlled Release Compositions Comprising a Platelet Aggregation Inhibitor |
| WO2007037790A2 (fr) | 2005-06-08 | 2007-04-05 | Elan Corporation, Plc | Compositions famciclovir à libération modifiée |
| DK2157973T3 (en) * | 2007-05-22 | 2015-08-17 | Univ Juntendo | DRUG COMPREHENSIVE A carbostyril derivative donepezil AND TREATMENT Alzheimer's disease |
| EP2429992A4 (fr) * | 2009-05-15 | 2012-11-28 | Univ Kentucky Res Found | Traitement du trouble cognitif léger et de la maladie d'alzheimer |
| RU2570424C2 (ru) * | 2009-12-15 | 2015-12-10 | МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи | Рапп-поддерживающие тиазолидиндионы и их комбинации для лечения нейродегенеративных заболеваний |
| CA2876371A1 (fr) * | 2012-06-15 | 2013-12-19 | Foundation For Biomedical Research And Innovation | Agent prophylactique et/ou therapeutique pour un trouble cognitif leger |
-
2013
- 2013-06-14 CA CA2876371A patent/CA2876371A1/fr not_active Abandoned
- 2013-06-14 MX MX2014015310A patent/MX2014015310A/es unknown
- 2013-06-14 WO PCT/JP2013/003740 patent/WO2013187075A1/fr active Application Filing
- 2013-06-14 BR BR112014031154A patent/BR112014031154A2/pt not_active IP Right Cessation
- 2013-06-14 EP EP13803699.1A patent/EP2862572B1/fr not_active Not-in-force
- 2013-06-14 KR KR1020157001022A patent/KR20150027800A/ko not_active Application Discontinuation
- 2013-06-14 AU AU2013275628A patent/AU2013275628A1/en not_active Abandoned
- 2013-06-14 CN CN201380031661.4A patent/CN104519884A/zh active Pending
- 2013-06-14 RU RU2015101100A patent/RU2015101100A/ru not_active Application Discontinuation
- 2013-06-14 US US14/407,692 patent/US20150152084A1/en not_active Abandoned
- 2013-06-14 SG SG11201408323RA patent/SG11201408323RA/en unknown
- 2013-06-14 JP JP2014520940A patent/JP5715303B2/ja not_active Expired - Fee Related
-
2014
- 2014-12-11 ZA ZA2014/09134A patent/ZA201409134B/en unknown
- 2014-12-14 IL IL236226A patent/IL236226A0/en unknown
-
2015
- 2015-03-12 JP JP2015049442A patent/JP6188737B2/ja not_active Expired - Fee Related
- 2015-09-21 US US14/860,057 patent/US9737524B2/en active Active
-
2017
- 2017-07-14 US US15/650,554 patent/US10016409B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2876371A1 (fr) | 2013-12-19 |
| AU2013275628A1 (en) | 2015-01-29 |
| US9737524B2 (en) | 2017-08-22 |
| BR112014031154A2 (pt) | 2017-08-08 |
| JP6188737B2 (ja) | 2017-08-30 |
| EP2862572A1 (fr) | 2015-04-22 |
| US20170312265A1 (en) | 2017-11-02 |
| ZA201409134B (en) | 2015-12-23 |
| EP2862572A4 (fr) | 2015-11-04 |
| US10016409B2 (en) | 2018-07-10 |
| WO2013187075A1 (fr) | 2013-12-19 |
| KR20150027800A (ko) | 2015-03-12 |
| EP2862572B1 (fr) | 2018-11-28 |
| JP5715303B2 (ja) | 2015-05-07 |
| RU2015101100A (ru) | 2016-08-10 |
| US20160008348A1 (en) | 2016-01-14 |
| IL236226A0 (en) | 2015-01-29 |
| US20150152084A1 (en) | 2015-06-04 |
| MX2014015310A (es) | 2015-07-06 |
| CN104519884A (zh) | 2015-04-15 |
| JP2015110665A (ja) | 2015-06-18 |
| JPWO2013187075A1 (ja) | 2016-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201408323RA (en) | Prophylactic and/or therapeutic agent for mild cognitive impairment | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| WO2013186777A3 (fr) | Utilisation d'agents bloquants de la signalisation par une protéine morphogénétique osseuse (bmp) pour le traitement de maladies neuroinflammatoires et neurodégénératives | |
| FI3811943T3 (fi) | Yhdiste käytettäväksi silmäsairauksien hoidossa | |
| NZ729796A (en) | Liquid inhalation formulation comprising rpl554 | |
| MY191380A (en) | Stabilized fixed dose drug composition having mometasone and olopatadine | |
| BR112014014262A2 (pt) | nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas. | |
| EP3015111A4 (fr) | Utilisation d'une préparation médicinale chinoise dans le cadre de la préparation d'un médicament permettant de prévenir et/ou de traiter la maladie de crohn | |
| EP3300734A3 (fr) | Utilisation de lévocétirizine et de montélukast dans le traitement des maladies auto-immunes | |
| HRP20161389T1 (hr) | Derivati pantotenata namijenjeni liječenju neuroloških poremećaja | |
| MX2018001918A (es) | Aplicación cuantitativa periorbital de farmacos oftalmologicos. | |
| JP2015523986A5 (fr) | ||
| WO2015048188A3 (fr) | Facteurs de croissance des fibroblastes modifiés pour le traitement de troubles oculaires | |
| UA109359C2 (xx) | Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном | |
| WO2016191458A3 (fr) | Compositions pharmaceutiques ayant un effet sur l'état d'oxydoréduction mitochondriale et méthodes de traitement associées | |
| WO2015165964A8 (fr) | Traitement et prévention de la maladie d'alzheimer | |
| BR112018072164A2 (pt) | composição farmacêutica, método para tratamento e/ou prevenção de uma doença de pele de um paciente e/ou para alívio dos sintomas da mesma, e, uso cosmético de uma composição | |
| PH12014502794A1 (en) | Prophylactic and/or therapeutic agent for mild cognitive impairment | |
| PH12016500563A1 (en) | 4-[5-(3-chloro-phenoxy)-oxazolo[5,4-d]pyrimidin-2-yl]-2,6-dimethyl-phenoxy}-acetic acid for use in the prevention or treatment of acute kidney injury | |
| PH12015502465A1 (en) | Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias | |
| MX2018013474A (es) | Acidos carboxilicos para aplicacion en la primera infancia. | |
| PL398967A1 (pl) | Zastosowanie kwasu loganowego w terapii jaskry | |
| Quintanilla-Licea et al. | ANTI-TRYPANOSOMA CRUZI ACTIVITY OF 20 MEDICINAL PLANTS USED IN NORTH EAST MEXICO | |
| RU2018110031A (ru) | Способ лечения и профилактика гриппа | |
| CN109771607A (zh) | 一种治疗失眠多梦用的中药 |